Contact Us

The choice depends on whether you are studying SLC35F2's role as a cellular uptake transporter for the cytotoxic compound YM155 (sepantronium bromide) or its emerging endogenous functions. The Knockout line is the standard tool for asking whether SLC35F2 is required for cellular YM155 uptake — SLC35F2 was identified through CRISPR screens as the principal transporter responsible for YM155 sensitivity, and its loss confers strong YM155 resistance. Overexpression is useful for studying YM155-targeted drug delivery strategies. For drug development research, the EDITGENE SLC35F2 Knockout in HCT 116 is particularly valuable — YM155 is being investigated for solid tumors and lymphomas, and SLC35F2 expression directly predicts YM155 sensitivity. Rescue with wild-type SLC35F2 restores YM155 sensitivity in resistant cells — this rescue paradigm is the established positive control. Rescue with transport-deficient variants enables structure-function studies.

Yes. SLC35F2 rescue experiments are well-established for YM155 drug uptake research: • Construct design: use a codon-modified SLC35F2 sequence with a small C-terminal tag (FLAG, HA). The 10 transmembrane SLC35 architecture must be preserved. • YM155 sensitivity restoration: rescue with wild-type SLC35F2 in YM155-resistant cells (e.g., the knockout) restores drug sensitivity — the established positive control paradigm. • Transport-deficient rescue: substrate-binding pocket mutations enable distinguishing transport activity from non-transport functions. • Functional readout: rescue should restore YM155-induced cytotoxicity (IC50 measurements) and intracellular YM155 accumulation (LC-MS). HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying p62's role as a selective autophagy receptor or its functions in NF-κB and Nrf2/Keap1 signaling. The Knockout line is the standard tool for asking whether p62 is required for selective autophagy of ubiquitinated cargo (aggrephagy, mitophagy, xenophagy). Overexpression is useful for studying p62's role in inclusion body formation or for testing p62 condensation/LLPS behavior. For autophagy research, the EDITGENE p62 Knockout in HeLa is a workhorse tool — HeLa has been the principal cell line for selective autophagy mechanism studies, with extensive published p62-dependent phenotypes. This product complements the parallel p62 Knockout in HEK293; HeLa is preferred for imaging-based aggrephagy studies given its flat morphology and well-characterized autophagy machinery. Rescue with wild-type, UBA-mutant (ubiquitin-binding-deficient), or LIR-mutant (LC3-binding-deficient) p62 enables comprehensive selective autophagy dissection.

Yes. p62 rescue experiments in HeLa are well-established for autophagy research: • Construct design: use a codon-modified SQSTM1 sequence with a small N- or C-terminal tag (FLAG, HA, GFP for imaging). p62 contains multiple functional domains (PB1, ZZ, TB, LIR, KIR, UBA) — small tags should be used to minimize domain disruption. • Domain-specific rescue panel: UBA mutation (K7A or domain deletion) abolishes ubiquitin binding; LIR mutation (W340A) abolishes LC3 binding — these constitute the standard selective autophagy specificity controls. • PB1-mutant rescue: PB1 domain mutations (D69A) abolish p62 oligomerization, separating LLPS-dependent functions from non-condensate functions. • Functional readout: rescue should restore selective autophagy of aggregated substrates and p62 puncta dynamics imaged in HeLa's flat morphology background. HeLa transduces efficiently with lentivirus; its imaging compatibility makes it particularly well-suited for fluorescent p62 rescue construct studies.

The choice depends on whether you are studying SMARCE1's role in the BAF (SWI/SNF) chromatin remodeling complex or its emerging functions in cancer biology, particularly in meningioma and small cell carcinoma of the ovary. The Knockout line is appropriate for asking whether SMARCE1 is required for BAF complex assembly and chromatin remodeling activity. Overexpression is useful for studying SMARCE1's role as a context-dependent transcriptional co-regulator. For chromatin remodeling research, the EDITGENE SMARCE1 Knockout in HEK293 provides a mechanistic platform — HEK293 supports the high-quality ChIP and biochemical analyses needed for BAF complex characterization. SMARCE1 mutations cause familial meningioma (clear cell subtype) and SCCOHT — disease variant rescue enables genotype-function studies. Rescue with wild-type or HMG-domain-mutant SMARCE1 enables structure-function dissection.

Yes. SMARCE1 rescue experiments require attention to BAF complex assembly: • Construct design: use a codon-modified SMARCE1 sequence with a small C-terminal tag (FLAG, HA). The N-terminal HMG-like domain mediates DNA binding and protein interactions — large N-terminal tags should be avoided. • HMG-domain-mutant rescue: HMG-box mutations affecting DNA binding distinguish DNA-engagement-dependent functions from scaffolding roles. • Disease mutation rescue: meningioma-associated (clear cell subtype) and SCCOHT-associated SMARCE1 variants enable genotype-function studies. • Functional readout: rescue should restore BAF complex composition (assessed by glycerol gradient) and chromatin occupancy of other BAF subunits. HEK293 transduces efficiently with lentivirus and supports the biochemical assays needed for BAF complex characterization.

The choice depends on whether you are studying SLC2A11 (GLUT11)'s role as a class II fructose-preferring glucose transporter or its tissue-specific functions in skeletal muscle, heart, and kidney. The Knockout line is the standard tool for asking whether GLUT11 is required for cellular hexose transport in non-classical contexts — GLUT11 has substrate selectivity favoring fructose over glucose. Overexpression is useful for testing transport activity in heterologous systems or for studying GLUT11's three reported splice isoforms (GLUT11-A, -B, -C with distinct tissue expression). For GLUT11 research, the EDITGENE Knockout in HEK293 is a mechanistic platform — HEK293 has been extensively used for GLUT family biochemistry. This product complements the parallel SLC2A11 Knockout in HCT 116 (also available); HEK293 is preferred for biochemistry and structure-function studies given its high transfection efficiency and established protocols. Rescue with wild-type, isoform-specific, or transport-deficient GLUT11 enables comprehensive structure-function analysis.

Yes. GLUT11 rescue experiments require attention to isoform diversity: • Construct design: use a codon-modified SLC2A11 sequence with a small C-terminal tag (FLAG, HA). GLUT11 has 12 transmembrane domains — preserve canonical GLUT family architecture. • Isoform-specific rescue: GLUT11-A (muscle/heart/kidney), GLUT11-B (kidney/adipose), and GLUT11-C (heart/skeletal muscle) have distinct N-termini — choose isoforms based on the experimental question. • Transport-deficient rescue: substrate-binding pocket mutations enable distinguishing fructose from glucose transport activities. • Functional readout: rescue should restore fructose and glucose uptake activities measured by radiolabel or LC-MS. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying CHIP's role as a co-chaperone E3 ubiquitin ligase for HSP70/HSP90 client proteins or its functions in protein quality control. The Knockout line is the standard tool for asking whether CHIP is required for ubiquitination of misfolded HSP70/HSP90 clients — its principal characterized function in proteostasis. Overexpression is useful for testing whether elevated CHIP enhances client protein degradation or for studying CHIP mutations associated with autosomal recessive spinocerebellar ataxia 16 (SCAR16). For protein quality control research, the EDITGENE STUB1/CHIP Knockout in HeLa is a tractable platform with established HSP70/HSP90 client biology. Rescue with wild-type, U-box-deleted (E3 ligase-dead), or TPR-domain-mutant (chaperone-binding-deficient) CHIP enables dissection of E3 ligase versus co-chaperone functions. SCAR16-associated mutations can be introduced for disease modeling.

Yes. CHIP rescue experiments are well-established given the maturity of HSP70/HSP90 quality control research: • Construct design: use a codon-modified STUB1 sequence with a small C-terminal tag (FLAG, HA). CHIP's N-terminal TPR domain binds HSP70/HSP90 EEVD motifs and C-terminal U-box mediates E3 ligase activity — both must be preserved. • U-box-deleted rescue: U-box mutation or deletion abolishes E3 ligase activity while preserving co-chaperone binding — the standard control for distinguishing ligase from chaperone-modulating functions. • TPR-mutant rescue: TPR domain mutations (e.g., K30A) disrupt HSP70/HSP90 binding without affecting U-box activity, enabling dissection of substrate-targeting from catalytic functions. • SCAR16 disease mutation rescue: introduction of autosomal recessive cerebellar ataxia 16-associated STUB1 mutations enables genotype-function correlation studies. HeLa transduces efficiently with lentivirus and is one of the most widely used cell lines for protein quality control research, with extensive established protocols for CHIP rescue experiments.

The choice depends on whether you are studying SLC2A11 (GLUT11)'s role in cancer cell hexose metabolism, particularly relevant for fructose handling in colorectal cancer contexts. The Knockout line is appropriate for asking whether GLUT11 contributes to fructose or glucose uptake in colorectal cancer cells — GLUT11's fructose preference makes it relevant for cancer cell sugar metabolism studies. Overexpression is useful for studying isoform-specific functions or for testing cancer-associated GLUT11 effects. For colorectal cancer fructose metabolism research, the EDITGENE Knockout in HCT 116 is particularly relevant — fructose has emerging roles in colorectal cancer progression, and GLUT11 may contribute to fructose acquisition in this context. This product complements the parallel SLC2A11 Knockout in HEK293 (also available); HCT 116 is preferred for cancer biology studies and intestinal-derived contexts. Rescue with wild-type or transport-deficient GLUT11 enables structure-function studies.

Yes. GLUT11 rescue in HCT 116 is well-suited for cancer biology research: • Construct design: use a codon-modified SLC2A11 sequence with a small C-terminal tag (FLAG, HA). Both N- and C-terminal cytoplasmic tags are typically tolerated. • Cancer phenotype rescue: assessment of proliferation, anchorage-independent growth, and fructose utilization restoration following GLUT11 rescue. • Transport-deficient rescue: substrate-binding pocket mutations enable distinguishing transport activity from non-transport functions in cancer biology. • Functional readout: rescue should restore fructose and glucose uptake activities and colorectal cancer-relevant metabolic phenotypes. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SP7's role as a master osteoblast transcription factor or its therapeutic implications in bone disease and osteosarcoma. The Knockout line is appropriate for asking whether SP7 is required for osteoblast-specific gene programs — particularly relevant in U2OS, which retains osteogenic gene expression features as an osteosarcoma cell line. Overexpression is useful for testing whether elevated SP7 is sufficient to drive osteoblast differentiation programs or for studying SP7 transactivation activity. For bone biology research, the EDITGENE SP7 Knockout in U2OS is particularly informative — U2OS expresses many osteoblast lineage markers and supports the assessment of SP7-dependent gene programs in an osteosarcoma genetic background. Rescue with wild-type or DNA-binding-deficient SP7 enables structure-function dissection. SP7 mutations cause osteogenesis imperfecta type XII — disease variant rescue enables genotype-phenotype correlation studies.

Yes. SP7 rescue experiments require attention to its zinc finger DNA-binding and proline-rich activation regions: • Construct design: use a codon-modified SP7 sequence with a small N- or C-terminal tag (FLAG, HA). SP7 contains three C2H2 zinc fingers in the DNA-binding region and a proline-rich transactivation region — both should be preserved. • DNA-binding-deficient rescue: zinc finger mutations (e.g., key cysteine substitutions) abolish GC-box binding and serve as the standard specificity control. • Disease mutation rescue: SP7 mutations causing osteogenesis imperfecta type XII can be introduced for genotype-phenotype correlation studies. • Functional readout: rescue should restore osteoblast target gene expression (COL1A1, BGLAP) and SP7 chromatin occupancy. U2OS transduces efficiently with lentivirus and supports stable rescue line generation; its flat morphology aids imaging-based analyses.

The choice depends on whether you are studying SPDEF's role as an ETS family transcription factor in goblet cell differentiation, secretory epithelium biology, or endometrial cancer. The Knockout line is appropriate for asking whether SPDEF is required for mucin gene expression and secretory cell programs — particularly relevant in HEC-1-B, an endometrial adenocarcinoma line where SPDEF has been implicated in disease progression. Overexpression is useful for studying SPDEF's pioneer transcription factor activity or for testing sufficiency for goblet cell-like differentiation. For SPDEF research, the EDITGENE Knockout in HEC-1-B is particularly relevant for endometrial cancer biology — HEC-1-B is one of the standard endometrial adenocarcinoma models, and SPDEF expression is a feature of this lineage. Rescue with wild-type or DNA-binding-deficient (ETS domain mutant) SPDEF enables structure-function dissection.